OHAfrica reaches significant milestone in HIV/AIDS treatment program in Africa

NewsGuard 100/100 Score

For more than five years, OHAfrica - through Tšepong Clinic - has helped support HIV/AIDS treatment and testing in Lesotho, a small country in southern Africa with the third highest HIV infection rate in the world.

Launched in December 2004, one of OHAfrica's primary goals has been to help Lesotho build a locally sustainable HIV/AIDS treatment program. Today, with Tšepong Clinic having reached that goal, OHAfrica has begun transitioning the program's clinical and managerial responsibilities to the Lesotho Ministry of Health and Social Welfare (MOHSW). The transition will be completed by March 31, 2010.

OHAfrica has accomplished a great deal in its time, including the introduction of antiretroviral (ARV) drug treatment programs for people living with HIV/AIDS in Lesotho, with Tšepong Clinic becoming one of the largest ARV treatment centres in the country, and increasing the number of registered patients from 116 to more than 11,300 patients.

"It's been a great privilege to work closely with the Ministry of Health and Social Welfare to design, implement and carry out a sustainable HIV/AIDS treatment program for the people of Lesotho," said Hilary Short, OHAfrica's Board Chair. "OHAfrica also acknowledges the talented Canadian health care professionals who shared their skills as well as the international partners and generous donors who have helped contribute to the success of our program."

As the transition from OHAfrica to the MOHSW takes place, OHAfrica will continue to provide clinical physician and nurse practitioner prescriber coverage for the month of January and nurse practitioner coverage to the end of February 2010. Management support will also be made available, if needed, throughout the month of February 2010.

OHAfrica is pleased to have worked in partnership with the MOHSW over the past five years to reach this significant milestone.

Source:

OHAFRICA

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research validates concurrent use of HIV medications and gender-affirming hormone therapy